MedTech News
Corify wins CE mark for cardiac mapping tech
Corify Care announced today that it received CE mark approval under the new medical device regulation (MDR) for its Acorys cardiac mapping system.
FDA clears CorVascular’s VasoGuard
CorVascular announced today that the FDA granted clearance for its VasoGuard V-Series portfolio of devices.
AliveDx Receives IVDR CE Mark for Groundbreaking Microarray Immunoassay in Allergy Diagnostics
EYSINS, Switzerland, July 29, 2024 /PRNewswire/ — AliveDx (“Company”) is proud to announce it has received IVDR CE mark for its groundbreaking microarray immunoassay, designed for the detection of a specific IgE directed to a protein allergen in human serum. This is the Company’s first product for the evaluation of allergies, enhancing its portfolio of products beyond autoimmunity.
New study shows ‘dancing molecules’ can regenerate cartilage in 3 days
In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving “dancing molecules,” to repair tissues and reverse paralysis after severe spinal cord injuries.
Scientists create novel anti-thrombogenic coatings to overcome endovascular therapy challenges
A researcher at AIST, in collaboration with the Japan Medical Startup Incubation Program (JMPR) and N.B. Medical Corporation, has developed a novel anti-thrombogenic coating for stents used in the treatment of intracranial aneurysms. The details of this technology were published in Scientific Reports on July 10, 2024.
We may soon have a faster test for sepsis: Study demonstrates ultra-rapid antimicrobial susceptibility testing method
A new method for identifying the pathogens involved in sepsis cases, which could help to select optimal therapeutics, is reported in Nature. The test has the potential to reduce the turnaround times normally associated with developing treatments for infections and may improve patient outcomes.
Alamar Biosciences Achieves ISO 13485 Certification, Demonstrating its Commitment to Quality and Safety
FREMONT, Calif., July 25, 2024 /PRNewswire/ — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announces that it has successfully achieved ISO 13485:2016 certification. This internationally recognized standard for quality management systems is specific to the medical devices industry and signifies Alamar Biosciences’ dedication to providing the highest quality products and services to its customers.
Wandercraft exoskeleton used in Olympic torch relay
A paraplegic person carried the Olympic torch as part of the traditional relay using an exoskeleton developed by Wandercraft.